This FDC aims to address the issue of Vitamin D3 and B12 deficiencies, concurrently seen in neuropathy patients due to nutritional deficiency.
The combination of Nervijen D3 consists of Methylcobalamin 1500mcg, Vitamin D3 1000 IU, Alpha Lipoic Acid 100mg, Folic acid 1.5mg, Benfotiamine 7.5mg, Inositol 1.5mg and Biotin 5mcg.
Methylcobalamin, an activated form of Vitamin B12, accelerates myelination, and may help in nerve cell and myelin sheath regeneration. Alpha lipoic acid is a potent antioxidant that helps to reduce oxidative stress and protect peripheral nerves from ischemia. Benfotiamine protects nerves against advanced glycation end products (AGE) formation, improves blood flow to nerves. Folic acid helps in DNA synthesis. Inositol helps in restoring depleted intracellular inositol levels and improves nerve conduction. Biotin boosts nerve function and improves nervous system metabolism. Adding to these constitutes, vitamin D3 increases nerve growth factor (NGF), maintains and improves nerve growth, reduces neuropathic pain, and prevents neuronal degeneration.
Approved by Drug Controller General of India (DCGI), the FDC of Nervijen D3 may help manage symptoms of lower back pain, cervical spondylitis, sciatica, radiculopathy, prolapsed intervertebral disk (PIVD), diabetic peripheral neuropathy, pre-diabetes, metabolic syndrome, cardiovascular disease, alcoholic neuropathy, Vit B12, and Vit D3 deficiency.
"Vitamin D3 and B12 deficiency is a silent epidemic in India with almost 75% percent of the population showing alarming levels of deficiency. It's a known fact that nutritional deficiency has a great influence on nerve repair and worsens neuropathy and it is to address this very need that we have now launched Nervijen D3 tablets the fixed dose combination of Methylcobalamin with Vitamin D3" said Mr Rahul Pimpale, Group Product Manager, Jenburkt Pharmaceuticals Ltd.
"Nervijen D3 will provide a strong therapeutic armamentarium to physicians, neurologists and orthopedicans, in their efforts to protect, repair and restore nerve functions in their patients. The tablets have been launched in small size for better patient compliance." added Mrs Pradnya Pant, Sr Product Manager, Jenburkt Pharmaceuticals Ltd.
Jenburkt Pharmaceuticals Ltd. is a public listed company established in 1985, and is a deeply trusted professionally run company. Jenburkt manufactures pharmaceutical formulations in India and markets them domestically and internationally as well across 13 countries. It is well known for brands like Powergesic and Nervijen.
Disclaimer: This post has been published under MD Brand Connect Initiative and is sponsored by Jenburkt Pharmaceuticals Ltd.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.